Corgenix Medical, in collaboration with Randox Laboratories, has filed first 510(k) premarket notification with the US Food and Drug Administration (FDA) for the TxBCardio immunoturbidimetric assay. According to Corgenix Medical, ...
Corgenix Medical, a developer of diagnostic test kits, has filed pre-market notification with the US Food and Drug Administration under Section 510(k) of the US Federal Food, Drug and Cosmetic Act for its hyaluronic acid (HA) enzyme-linked ...
Tags: Corgenix Medical
Corgenix Medical has received the notification of CE Mark for its Relasv antigen rapid test for Lassa fever diagnosis. Relasv is the diagnostic test developed by Corgenix and members of the Viral Hemorrhagic Fever Consortium (VHFC), a ...
Tags: Corgenix Medical, Rapid Test
Corgenix Medical has received additional patent covering its AspirinWorks technology from the US Patent and Trademark Office. The patent is issued for the AspirinWorks Test Kit, which measures thromboxane metabolites in urine to evaluate ...
Tags: AspirinWorks technology, AspirinWorks test kit, Corgenix Medical
Corgenix, a subsidiary of Corgenix Medical, has signed a five-year contract manufacturing and supply agreement with diaDexus. As per the agreement, Corgenix will manufacture and supply the PLAC blood test ELISA product for diaDexus. The ...